nAMDのステレオタキシ放射線療法:改善すべき分野 - 著者の回答
Timothy L Jackson1, Helen Dakin2, Xuemin Zhu2
1Faculty of Life Sciences and Medicine, King's College London, London WC2R 2LS, UK; King's Ophthalmology Research Unit, King's College Hospital, London, UK.
Lancet (London, England)
|July 5, 2025
まとめ
No abstract available in PubMed .


